1,25(OH)2D3 increases osteogenic potential of human periodontal ligament cells with low osteoblast potential

Periodontal dental ligament mesenchymal stem cells (PDLMSCs) play a major role in the regeneration of periodontal tissue through the neoformation of root cementum and alveolar bone. These cells are highly heterogeneous, and many present low potential to renovate the hard tissue damaged by periodontal disease. A previous study found that the low osteoblast/cementoblast (O/C) differentiation potential of PDLMSCs is related to high asporin (ASPN) expression, which was identified as a negative regulator of PDL cells differentiation and mineralization suppressing BMP-2-induced O/C differentiation. Objective: This study aimed to investigate whether 1,25(OH)2D3 treatment could stimulate the O/C differentiation of periodontal ligament mesenchymal progenitor cells characterized as low osteoblast potential (LOP), through asporin and bone morphogenetic protein-2 alteration. Methodology: Three LOP cell populations were cultured in standard medium (CONTROL), osteogenic medium (OM), and osteogenic medium associated with 1 nM of 1,25(OH)2D3 (OM + VD). The following assays were performed: 1) MTT to evaluate metabolic activity, 2) gene expression for asporin (ASPN), bone morphogenetic protein-2 (BMP-2), runt-related transcription factor 2 (RUNX2), alkaline phosphatase (ALP), osteocalcin (OCN), and vitamin D receptor (VDR) using qRT-PCR, 3) BMP-2 extracellular expression, and 4) quantification of mineralized nodule deposition by alizarin red staining. Data were subjected to two-way ANOVA and Tukey’s test (p<0.05). Results: The results showed that the 1,25(OH)2D3 treatment did not affect the cell viability as demonstrated by increasing metabolic activity over the 10 days in culture. After 14 days of 1,25(OH)2D3 treatment, the mRNA levels for ASPN and VDR decreased (P < 0.05), while BMP-2 transcripts and extracellular expression increased (P < 0.05). In parallel, RUNX2, ALP, and OCN gene expression was upregulated by 1,25(OH)2D3 treatment, resulting in an increase of mineral nodule deposition in vitro (P < 0.05). Conclusions: These data show that 1,25(OH)2D3 improves osteoblast/cementoblast differentiation of low osteoblast potential accompanied by alterations in ASPN and BMP-2 expression. (2024-04-16)